Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex vs Neostigmine for NMB Reversal in Gynecologic Laparotomy
NCT03519724Phase 2Unknown
- Sponsor
- Università Campus Bio-Medico di Roma
- Start
- Jul 2018
- Primary completion
- Sep 2018
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Sugammadex in Postoperative residual curarization (PORC), sponsored by Università Campus Bio-Medico di Roma. Status: unknown.
02
Drugs
Sugammadex
03
Conditions
Postoperative residual curarization (PORC)
Beyond the preview
Go deeper on NCT03519724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03519724.